Clinical Trials Browser

Phase 3 × peginterferon alfa-2b × Dermatologic × Clear all

NCT00221702 2010-10-13

EADO

Phase 3 Completed

Melanoma, Neoplasm Metastasis, Drug-Related Side Effects and Adverse Reactions